Soy isoflavone exposure through all life stages accelerates 17β-estradiol-induced mammary tumor onset and growth, yet reduces tumor burden, in ACI rats.
about
State of the evidence 2017: an update on the connection between breast cancer and the environmentRat Models of 17beta-Estradiol-Induced Mammary Cancer Reveal Novel Insights into Breast Cancer Etiology and Prevention.[Isoflavone-containing dietary supplements].Evaluation of the isoflavones and estrogen effects on the rat adrenal.Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation
P2860
Soy isoflavone exposure through all life stages accelerates 17β-estradiol-induced mammary tumor onset and growth, yet reduces tumor burden, in ACI rats.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Soy isoflavone exposure throug ...... ces tumor burden, in ACI rats.
@en
Soy isoflavone exposure throug ...... ces tumor burden, in ACI rats.
@nl
type
label
Soy isoflavone exposure throug ...... ces tumor burden, in ACI rats.
@en
Soy isoflavone exposure throug ...... ces tumor burden, in ACI rats.
@nl
prefLabel
Soy isoflavone exposure throug ...... ces tumor burden, in ACI rats.
@en
Soy isoflavone exposure throug ...... ces tumor burden, in ACI rats.
@nl
P2093
P2860
P1476
Soy isoflavone exposure throug ...... ces tumor burden, in ACI rats.
@en
P2093
Daniela Pemp
Frank Josef Möller
Günter Vollmer
Kathleen Wende
Maarten C Bosland
Michael H Muders
Oliver Zierau
Sebastian T Soukup
Xiajie Zhang
P2860
P2888
P304
P356
10.1007/S00204-016-1674-2
P577
2016-02-09T00:00:00Z